Silo Pharma (SILO)
NASDAQ:SILO
Total Valuation
Silo Pharma has a market cap or net worth of $6.26M. The enterprise value is -$1.42M.
Market Cap$6.26M
Enterprise Value-$1.42M
Share Statistics
Silo Pharma has 14,166,593 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,166,593
Owned by Insiders1.67%
Owned by Institutions7.01%
Financial Efficiency
Silo Pharma’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -61.55%.
Return on Equity (ROE)-0.67
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-61.55%
Return on Capital Employed (ROCE)-0.62
Revenue Per Employee24.03K
Profits Per Employee-1.41M
Employee Count3
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Silo Pharma is ―. Silo Pharma’s PEG ratio is 0.01.
PE Ratio―
PS Ratio39.53
PB Ratio0.45
Price to Fair Value0.45
Price to FCF-0.61
Price to Operating Cash Flow-1.51
PEG Ratio0.01
Income Statement
In the last 12 months, Silo Pharma had revenue of 72.10K and earned -4.23M in profits. Earnings per share was -0.50.
Revenue72.10K
Gross Profit-813.96K
Operating Income-4.28M
Pretax Income-4.23M
Net Income-4.23M
EBITDA-4.28M
Earnings Per Share (EPS)-0.50
Cash Flow
In the last 12 months, operating cash flow was -4.66M and capital expenditures 3.00, giving a free cash flow of -4.66M billion.
Operating Cash Flow-4.66M
Free Cash Flow-4.66M
Free Cash Flow per Share-0.33
Dividends & Yields
Silo Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.37
52-Week Price Change-57.50%
50-Day Moving Average0.34
200-Day Moving Average0.50
Relative Strength Index (RSI)59.49
Average Volume (3m)2.39M
Important Dates
Silo Pharma upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Silo Pharma as a current ratio of 11.36, with Debt / Equity ratio of 0.00%
Current Ratio11.36
Quick Ratio11.36
Debt to Market Cap0.00
Net Debt to EBITDA1.11
Interest Coverage Ratio-114.76
Taxes
In the past 12 months, Silo Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Silo Pharma EV to EBITDA ratio is 0.44, with an EV/FCF ratio of 0.41.
EV to Sales-26.33
EV to EBITDA0.44
EV to Free Cash Flow0.41
EV to Operating Cash Flow0.41
Balance Sheet
Silo Pharma has $6.86M in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.86M billion.
Cash & Marketable Securities$6.86M
Total Debt$0.00
Net Cash$6.86M
Net Cash Per Share$0.48
Tangible Book Value Per Share$0.73
Margins
Gross margin is -602.78%, with operating margin of -5936.95%, and net profit margin of -5863.50%.
Gross Margin-602.78%
Operating Margin-5936.95%
Pretax Margin-5863.50%
Net Profit Margin-5863.50%
EBITDA Margin-5936.95%
EBIT Margin-5936.95%
Analyst Forecast
The average price target for Silo Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―